SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-204467
Filing Date
2013-05-07
Accepted
2013-05-07 16:17:08
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d500777d10q.htm 10-Q 414436
2 EX-31.1 d500777dex311.htm EX-31.1 6685
3 EX-31.2 d500777dex312.htm EX-31.2 6541
4 EX-32.1 d500777dex321.htm EX-32.1 4140
5 EX-32.2 d500777dex322.htm EX-32.2 4045
  Complete submission text file 0001193125-13-204467.txt   2394837

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acad-20130331.xml EX-101.INS 275934
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20130331.xsd EX-101.SCH 25850
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20130331_cal.xml EX-101.CAL 36571
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20130331_def.xml EX-101.DEF 144032
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20130331_lab.xml EX-101.LAB 185394
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20130331_pre.xml EX-101.PRE 169157
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 13820222
SIC: 2834 Pharmaceutical Preparations